Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot

被引:16
|
作者
Parigi, Tommaso Lorenzo [1 ]
D'Amico, Ferdinando [1 ,2 ]
Danese, Silvio [1 ,2 ]
机构
[1] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini, I-20090 Milan, Italy
[2] Humanitas Clin & Res Ctr, IBD Ctr, Milan, Italy
关键词
INHIBITORS; EFFICACY; SAFETY;
D O I
10.1053/j.gastro.2020.04.034
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1472 / 1474
页数:4
相关论文
共 50 条
  • [31] UPADACITINIB IS EFFECTIVE AND SAFE FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE: 1-YEAR PROSPECTIVE REAL-WORLD EXPERIENCE
    Cleveland, Noa Krugliak
    Choi, Natalie K.
    Klein, Jeremy A.
    Fear, Evan N.
    Fine, Zachary D.
    Garcia, Nicole M.
    Picker, Emma A.
    Friedberg, Scott
    Cohen, Russell D.
    Dalal, Sushila R.
    Pekow, Joel
    Choi, David
    Rubin, David T.
    GASTROENTEROLOGY, 2024, 166 (05) : S1141 - S1142
  • [32] Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience
    Friedberg, Scott
    Choi, David
    Hunold, Thomas
    Choi, Natalie K.
    Garcia, Nicole M.
    Picker, Emma A.
    Cohen, Nathaniel A.
    Cohen, Russell D.
    Dalal, Sushila R.
    Pekow, Joel
    Sakuraba, Atsushi
    Cleveland, Noa Krugliak
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1913 - +
  • [33] Upadacitinib for Severe Crohn's-Like Enteritis Following Colectomy for Ulcerative Colitis
    Chan, Leona
    Lam, Eric
    Leung, Yvette
    Kiow, Jeremy Liu Chen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2551 - S2552
  • [34] Experimental Inflammatory Bowel Disease: Lessons for the Treatment of Crohn's Disease and Ulcerative Colitis
    Ivan Fuss
    Pediatric Research, 1999, 45 : 746 - 746
  • [35] Experimental inflammatory dowel disease: Lessons for the treatment of Crohn's disease and ulcerative colitis
    Fuss, I
    PEDIATRIC RESEARCH, 1999, 45 (05) : 746 - 746
  • [36] Role of diet in prevention versus treatment of Crohn's disease and ulcerative colitis
    Halmos, Emma P.
    Godny, Lihi
    Vanderstappen, Julie
    Sarbagili-Shabat, Chen
    Svolos, Vaios
    FRONTLINE GASTROENTEROLOGY, 2024, 15 (03) : 247 - 257
  • [37] Integrated Safety Analysis of Vedolizumab for the Treatment of Ulcerative Colitis or Crohn's Disease
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Feagan, Brian G.
    Loftus, Edward V.
    Sankoh, Serap
    Fox, Irving
    Parikh, Asit
    Milch, Catherine
    GASTROENTEROLOGY, 2013, 144 (05) : S113 - S113
  • [38] Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment
    Le Berre, Catherine
    Ananthakrishnan, Ashwin N.
    Danese, Silvio
    Singh, Siddharth
    Peyrin-Biroulet, Laurent
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) : 14 - 23
  • [39] Benefit–Risk Assessment of Vedolizumab in the Treatment of Crohn’s Disease and Ulcerative Colitis
    Robert Battat
    Christopher Ma
    Vipul Jairath
    Reena Khanna
    Brian G. Feagan
    Drug Safety, 2019, 42 : 617 - 632
  • [40] Costs of treatment of Crohn's disease and ulcerative colitis in US children and adults
    Kappelman, Michael D.
    Rifas-Shiman, Sheryl
    Porter, Carol Q.
    Oflenclorf, Daniel A.
    Sandler, Robert
    Finkelstein, Jonathan A.
    GASTROENTEROLOGY, 2008, 134 (04) : A155 - A156